|
Research Management and Support - Total
|
RMS2012 [E]
|
$374,919,382
|
N/A
|
(NCI)
|
|
Exergaming Intervention and Breast Cancer Biomarkers in Black Women
|
1R21CA165067-01A1
|
$178,058
|
ADAMS-CAMPBELL, LUCILE
|
GEORGETOWN UNIVERSITY
|
|
Role of Physical Properties in Pharmacokinetics, Biodistribution and Tumor Uptake
|
5F31CA150566-03
|
$33,671
|
Adjei, Isaac
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities ( 1 of 3)
|
5U54CA163069-02
|
$1,328,312
|
Adunyah, Samuel
|
MEHARRY MEDICAL COLLEGE
|
|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-09
|
$216,434
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Targeting Endoplasmic Reticulum Stress Response for Cancer Therapy
|
7R01CA152312-02
|
$368,100
|
AKTAS, BERTAL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Estrogen Receptor Alpha Proteostasis in Breast Cancer
|
5R01CA159578-02
|
$310,658
|
Alarid, Elaine
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119-02020
|
$1,451,134
|
Alavanja, Michael
|
DCEG (NCI)
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-34S1
|
$75,000
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-34S2
|
$143,846
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
5P30CA023074-34
|
$3,953,813
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Southeast Michigan Community Network Program
|
5U54CA153606-03
|
$780,541
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
Characterization of WWOX, the Cancer Gene Spanning FRA16D
|
5R01CA102444-08
|
$333,032
|
Aldaz, Claudio
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
The Role of Syndecan-1 in Mouse Mammary Neoplasia
|
5R01CA090877-10
|
$286,318
|
ALEXANDER, CAROLINE
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Assessments of Multiple Breast Cancer Biomarkers with Dendritic MRI Probes
|
5K25CA129173-04
|
$131,282
|
ALI, MESER
|
HENRY FORD HEALTH SYSTEM
|
|
Combined Acoustic Imaging and Viscoelastic Parameters Estimation in Breast Cancer
|
5R01CA148994-02
|
$488,454
|
Alizad, Azra
|
MAYO CLINIC
|
|
Multiplexed Measurement of Kinase Activity in Single Cancer Cells
|
5R01CA139599-04
|
$552,746
|
Allbritton, Nancy
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Margin Detection using Infrared Spectroscopy and Plasmon Resonance
|
1R21CA167403-01
|
$194,153
|
Allen, Heather
|
OHIO STATE UNIVERSITY
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144-07130
|
$1,264,778
|
Alter, Blanche
|
DCEG (NCI)
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-43S1
|
$127,557
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-43
|
$2,516,654
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
Control of Apoptosis in Cancer by Survivin
|
5R01CA078810-15
|
$301,698
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
Rational Design and Clinical Development of Shepherdin: A Novel Anti-Cancer Agent
|
5R01CA118005-05
|
$350,890
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
Epidemiology of Breast Cancer Subtypes in African American Women: a Consortium
|
5P01CA151135-02
|
$3,641,180
|
Ambrosone, Christine
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
DNA Methylation: a Mechanism for Aggressive Breast Cancer in African-American Wom
|
5R01CA133264-03
|
$917,953
|
Ambrosone, Christine
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Genome-Wide Predictors of Treatment-Related Toxicities
|
5R01CA139426-02
|
$964,435
|
Ambrosone, Christine
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Novel Markers for Disease Outcome in Breast Cancer
|
ZIABC010887
|
$294,527
|
Ambs, Stefan
|
CCR (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIABC010030
|
$806,557
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
PARP Inhibition to Treat Triple-Negative Breast Cancer Brain Metastases
|
5K23CA157728-02
|
$173,089
|
Anders, Carey
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Biobehavioral responses to cancer
|
5K05CA098133-08
|
$160,410
|
Andersen, Barbara
|
OHIO STATE UNIVERSITY
|
|
PI Signaling Role in Epithelial/Mesenchymal Transition
|
5R01CA104708-08
|
$288,391
|
ANDERSON, RICHARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Is GLUT1 required for tumor growth and the Warburg Effect?
|
5R01CA138482-02
|
$181,829
|
ANDERSON, STEVEN
|
UNIVERSITY OF COLORADO DENVER
|
|
Patterns of Patient Care in Appalachia
|
5R01CA140335-03
|
$412,470
|
ANDERSON, ROGER
|
PENNSYLVANIA STATE UNIVERSITY
|
|
SEER Special Studies
|
ZIA CP010183-10316
|
$57,766
|
Anderson, Bill
|
DCEG (NCI)
|
|
Entirely Carbohydrate Vaccine Constructs and Their Application in Probing Glycoim
|
5R01CA156661-02
|
$298,591
|
Andreana, Peter
|
WAYNE STATE UNIVERSITY
|
|
Dissecting Tumor Heterogeneity by Analyzing Signaling Pathway Requirements.
|
1R01CA160514-01A1
|
$308,831
|
Andrechek, Eran
|
MICHIGAN STATE UNIVERSITY
|
|
LEGACY: A cohort of youth in families from the Breast Cancer Family Registry
|
5R01CA138844-02
|
$372,297
|
Andrulis, Irene
|
MT SINAI HOSP-SAMUEL LUNENFELD RES INST
|
|
Evaluation of HSET as a Novel Theranostic Target for Breast Cancer Therapy
|
1R01CA169127-01
|
$299,838
|
Aneja, Ritu
|
GEORGIA STATE UNIVERSITY
|
|
Evaluation of antiangiogenic role of EM011, a novel tubulin-binding agent
|
5R00CA131489-05
|
$241,529
|
Aneja, Ritu
|
GEORGIA STATE UNIVERSITY
|
|
TRAINING IN CANCER BIOLOGY AND TRANSPLANTATION
|
5T32CA009515-28
|
$613,461
|
APPELBAUM, FREDERICK
|
UNIVERSITY OF WASHINGTON
|
|
Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells
|
ZIABC011197
|
$461,568
|
Appella, Ettore
|
CCR (NCI)
|
|
Racial Differences in BRCA1/2 Testing: Patients or Providers?
|
5R01CA133004-04
|
$464,663
|
ARMSTRONG, KATRINA
|
UNIVERSITY OF PENNSYLVANIA
|
|
Penn Center for Innovation in Personalized Breast Screening
|
5U54CA163313-02
|
$1,038,923
|
ARMSTRONG, KATRINA
|
UNIVERSITY OF PENNSYLVANIA
|
|
Notch Signaling in Mammary Development and Tumorigenesis
|
5R01CA098402-10
|
$357,272
|
ARTAVANIS-TSAKONAS, SPYRIDON
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
|
SPORE in Breast Cancer
|
5P50CA098131-10
|
$2,300,000
|
ARTEAGA, CARLOS
|
VANDERBILT UNIVERSITY MED CTR
|
|
Erbb2 targeted antitumor strategies in breast cancer
|
5R01CA080195-12
|
$312,562
|
ARTEAGA, CARLOS
|
VANDERBILT UNIVERSITY MED CTR
|
|
Image-guided combination therapy: noninvasive assessment of delivery and response
|
5R01CA154738-02
|
$595,990
|
ARTEMOV, DMITRI
|
JOHNS HOPKINS UNIVERSITY
|
|
SOUTHEAST CANCER CONTROL COSORTIUM, INC
|
3U10CA045808-18S1
|
$323,511
|
Atkins, James
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-26
|
$1,476,477
|
Atkins, James
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Telomeres, telomerase and chemotherapy: Bench to bedside
|
5R01CA077091-09
|
$333,500
|
Au, Jessie
|
OPTIMUM THERAPEUTICS, LLC
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|